MDMG OPENS A NEW ONCOLOGICAL CARE CENTRE
4 October 2021, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces the opening of a second outpatient Oncological Care Centre.
The outpatient Oncological Care Center has been operating since the end of September and is situated in Mozhaisk, a district center of the Moscow Region, and is located inside the Mozhaisk Central Hospital. The total area of the center is 450 sq. m. This is the second center of the Group with a similar specialization. The first center has been functioning inside the Lapino-2 clinical hospital since the first quarter of 2021.
The new center provides verification of the diagnosis and referral for treatment for patients with oncology issues. The center has the following services – consultations by an oncologist, functional diagnostics, ultrasound scan, endoscopy (gastroscopy, colonoscopy), radiodiagnosis, a procedure room. If necessary, patients can receive effective oncology drug therapy in a daytime in-patient ward.
Total investment in the project amounts to 60 million rubles. Planned admission - 60 patients per shift. Medical services at the center are provided only under the MHI program.
Mark Kurtser, CEO of MD Medical Group, said: "We are continuing to expand our medical network in one of the most dynamically developing regions of Russia - the Moscow region and are focusing on oncology. By opening our new center in Mozhaisk we are providing access to high quality oncological care for residents of one of the distant districts of the Moscow region. After consultations with our doctors in Mozhaisk patients may be directed for additional check-ups or treatment at our Lapino hospital which provides chemotherapy or necessary surgery on a high medical level also in the format of the MHI program".relation to GDRs.
MD Medical Group Investments Plc
Tel: +7 (495) 139-87-40, ext. 16329
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +7 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Since November 9, 2020 the Company's GDRs are traded also on the Moscow Exchange. Quotation is done in Russian Rubles.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.